Does the media favor ACU or QDEL?

In the previous week, QuidelOrtho had 7 more articles in the media than Acme United. MarketBeat recorded 10 mentions for QuidelOrtho and 3 mentions for Acme United. Acme United's average media sentiment score of 0.67 beat QuidelOrtho's score of 0.50 indicating that Acme United is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Acme United 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive QuidelOrtho 2 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings & valuation, ACU or CERS?

Acme United has higher revenue and earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Acme United $220.55M 1.18 $17.79M $2.72 25.17 Cerus $206.13M 1.94 -$15.63M -$0.03 N/A

Is ACU or CERS more profitable?

Acme United has a net margin of 10.25% compared to Cerus' net margin of -3.23%. Acme United's return on equity of 9.70% beat Cerus' return on equity. Company Net Margins Return on Equity Return on Assets Acme United 10.25% 9.70% 6.10% Cerus -3.23% -10.44% -3.42%

Does the media favor ACU or CERS?

In the previous week, Acme United and Acme United both had 3 articles in the media. Cerus' average media sentiment score of 0.70 beat Acme United's score of 0.67 indicating that Cerus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Acme United 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cerus 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, ACU or EMBC?

Embecta has higher revenue and earnings than Acme United. Embecta is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Acme United $220.55M 1.18 $17.79M $2.72 25.17 Embecta $1.08B 0.34 $95.40M $1.48 4.36

Is ACU or EMBC more profitable?

Acme United has a net margin of 10.25% compared to Embecta's net margin of 8.59%. Acme United's return on equity of 9.70% beat Embecta's return on equity. Company Net Margins Return on Equity Return on Assets Acme United 10.25% 9.70% 6.10% Embecta 8.59% -19.25% 10.82%

Does the media prefer ACU or EMBC?

In the previous week, Embecta had 1 more articles in the media than Acme United. MarketBeat recorded 4 mentions for Embecta and 3 mentions for Acme United. Embecta's average media sentiment score of 1.03 beat Acme United's score of 0.67 indicating that Embecta is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Acme United 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Embecta 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, SMTI or ACU?

Acme United has higher revenue and earnings than Sanara MedTech. Sanara MedTech is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sanara MedTech $103.12M 2.88 -$37.56M -$3.59 N/A Acme United $220.55M 1.18 $17.79M $2.72 25.17

Does the media refer more to SMTI or ACU?

In the previous week, Sanara MedTech had 2 more articles in the media than Acme United. MarketBeat recorded 5 mentions for Sanara MedTech and 3 mentions for Acme United. Acme United's average media sentiment score of 0.67 beat Sanara MedTech's score of -0.03 indicating that Acme United is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sanara MedTech 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Acme United 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend ACU or OSUR?

Acme United presently has a consensus target price of $70.00, suggesting a potential upside of 2.25%. Given Acme United's higher probable upside, research analysts clearly believe Acme United is more favorable than OraSure Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Acme United 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 OraSure Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33

Does the media refer more to ACU or OSUR?

In the previous week, OraSure Technologies had 12 more articles in the media than Acme United. MarketBeat recorded 15 mentions for OraSure Technologies and 3 mentions for Acme United. Acme United's average media sentiment score of 0.67 beat OraSure Technologies' score of 0.65 indicating that Acme United is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Acme United 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OraSure Technologies 3 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Acme United (ACU) Competitors

$68.46 -1.76 (-2.51%)

Closing price 11/13/2026 04:00 PM Eastern

Extended Trading

$68.28 -0.17 (-0.26%)

As of 11/13/2026 07:30 PM Eastern

Compare

ACU vs. QDEL, CERS, EMBC, SMTI, and OSUR

Should you buy Acme United stock or one of its competitors? Acme United's main competitors and comparable companies include QuidelOrtho (QDEL), Cerus (CERS), Embecta (EMBC), Sanara MedTech (SMTI), and OraSure Technologies (OSUR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Acme United compare to QuidelOrtho?

Acme United (NYSE:ACU) and QuidelOrtho (NASDAQ:QDEL) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation, media sentiment and institutional ownership.

62.1% of Acme United shares are owned by institutional investors. Comparatively, 99.0% of QuidelOrtho shares are owned by institutional investors. 29.5% of Acme United shares are owned by company insiders. Comparatively, 1.1% of QuidelOrtho shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Acme United has a beta of 0.35, meaning that its stock price is 65% less volatile than the broader market. Comparatively, QuidelOrtho has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market.

Acme United has a net margin of 10.25% compared to QuidelOrtho's net margin of -14.24%. Acme United's return on equity of 9.70% beat QuidelOrtho's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Acme United	10.25%	9.70%	6.10%
QuidelOrtho	-14.24%	3.22%	1.03%

Acme United has higher earnings, but lower revenue than QuidelOrtho. QuidelOrtho is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acme United	$220.55M	1.18	$17.79M	$2.72	25.17
QuidelOrtho	$2.73B	0.27	-$1.13B	-$5.41	N/A

In the previous week, QuidelOrtho had 7 more articles in the media than Acme United. MarketBeat recorded 10 mentions for QuidelOrtho and 3 mentions for Acme United. Acme United's average media sentiment score of 0.67 beat QuidelOrtho's score of 0.50 indicating that Acme United is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Acme United	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
QuidelOrtho	2 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Acme United currently has a consensus price target of $70.00, indicating a potential upside of 2.25%. QuidelOrtho has a consensus price target of $13.63, indicating a potential upside of 26.86%. Given QuidelOrtho's higher possible upside, analysts clearly believe QuidelOrtho is more favorable than Acme United.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acme United	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
QuidelOrtho	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Summary

Acme United beats QuidelOrtho on 10 of the 15 factors compared between the two stocks.

How does Acme United compare to Cerus?

Acme United (NYSE:ACU) and Cerus (NASDAQ:CERS) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation, media sentiment and analyst recommendations.

Acme United has higher revenue and earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acme United	$220.55M	1.18	$17.79M	$2.72	25.17
Cerus	$206.13M	1.94	-$15.63M	-$0.03	N/A

Acme United has a beta of 0.35, indicating that its stock price is 65% less volatile than the broader market. Comparatively, Cerus has a beta of 1.84, indicating that its stock price is 84% more volatile than the broader market.

Acme United currently has a consensus price target of $70.00, suggesting a potential upside of 2.25%. Cerus has a consensus price target of $5.25, suggesting a potential upside of 164.48%. Given Cerus' stronger consensus rating and higher probable upside, analysts plainly believe Cerus is more favorable than Acme United.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acme United	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cerus	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Acme United has a net margin of 10.25% compared to Cerus' net margin of -3.23%. Acme United's return on equity of 9.70% beat Cerus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Acme United	10.25%	9.70%	6.10%
Cerus	-3.23%	-10.44%	-3.42%

62.1% of Acme United shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 29.5% of Acme United shares are held by insiders. Comparatively, 5.3% of Cerus shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Acme United and Acme United both had 3 articles in the media. Cerus' average media sentiment score of 0.70 beat Acme United's score of 0.67 indicating that Cerus is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Acme United	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cerus	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Acme United beats Cerus on 8 of the 15 factors compared between the two stocks.

How does Acme United compare to Embecta?

Acme United (NYSE:ACU) and Embecta (NASDAQ:EMBC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

62.1% of Acme United shares are owned by institutional investors. Comparatively, 93.8% of Embecta shares are owned by institutional investors. 29.5% of Acme United shares are owned by company insiders. Comparatively, 1.3% of Embecta shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Acme United has a beta of 0.35, suggesting that its share price is 65% less volatile than the broader market. Comparatively, Embecta has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market.

Embecta has higher revenue and earnings than Acme United. Embecta is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acme United	$220.55M	1.18	$17.79M	$2.72	25.17
Embecta	$1.08B	0.34	$95.40M	$1.48	4.36

Acme United pays an annual dividend of $0.64 per share and has a dividend yield of 0.9%. Embecta pays an annual dividend of $0.04 per share and has a dividend yield of 0.6%. Acme United pays out 23.5% of its earnings in the form of a dividend. Embecta pays out 2.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Acme United has increased its dividend for 20 consecutive years. Acme United is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Acme United presently has a consensus target price of $70.00, suggesting a potential upside of 2.25%. Embecta has a consensus target price of $11.00, suggesting a potential upside of 70.28%. Given Embecta's higher possible upside, analysts clearly believe Embecta is more favorable than Acme United.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acme United	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Embecta	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

Acme United has a net margin of 10.25% compared to Embecta's net margin of 8.59%. Acme United's return on equity of 9.70% beat Embecta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Acme United	10.25%	9.70%	6.10%
Embecta	8.59%	-19.25%	10.82%

In the previous week, Embecta had 1 more articles in the media than Acme United. MarketBeat recorded 4 mentions for Embecta and 3 mentions for Acme United. Embecta's average media sentiment score of 1.03 beat Acme United's score of 0.67 indicating that Embecta is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Acme United	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Embecta	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Acme United and Embecta tied by winning 9 of the 18 factors compared between the two stocks.

How does Acme United compare to Sanara MedTech?

Sanara MedTech (NASDAQ:SMTI) and Acme United (NYSE:ACU) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership.

In the previous week, Sanara MedTech had 2 more articles in the media than Acme United. MarketBeat recorded 5 mentions for Sanara MedTech and 3 mentions for Acme United. Acme United's average media sentiment score of 0.67 beat Sanara MedTech's score of -0.03 indicating that Acme United is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sanara MedTech	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Acme United	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Acme United has higher revenue and earnings than Sanara MedTech. Sanara MedTech is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanara MedTech	$103.12M	2.88	-$37.56M	-$3.59	N/A
Acme United	$220.55M	1.18	$17.79M	$2.72	25.17

Sanara MedTech has a beta of 1.23, indicating that its stock price is 23% more volatile than the broader market. Comparatively, Acme United has a beta of 0.35, indicating that its stock price is 65% less volatile than the broader market.

8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 62.1% of Acme United shares are held by institutional investors. 42.0% of Sanara MedTech shares are held by company insiders. Comparatively, 29.5% of Acme United shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Acme United has a net margin of 10.25% compared to Sanara MedTech's net margin of -2.69%. Sanara MedTech's return on equity of 32.45% beat Acme United's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanara MedTech	-2.69%	32.45%	3.21%
Acme United	10.25%	9.70%	6.10%

Sanara MedTech presently has a consensus price target of $35.00, suggesting a potential upside of 8.19%. Acme United has a consensus price target of $70.00, suggesting a potential upside of 2.25%. Given Sanara MedTech's higher possible upside, research analysts plainly believe Sanara MedTech is more favorable than Acme United.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanara MedTech	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80
Acme United	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Acme United beats Sanara MedTech on 9 of the 15 factors compared between the two stocks.

How does Acme United compare to OraSure Technologies?

Acme United (NYSE:ACU) and OraSure Technologies (NASDAQ:OSUR) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

62.1% of Acme United shares are held by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are held by institutional investors. 29.5% of Acme United shares are held by insiders. Comparatively, 4.7% of OraSure Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, OraSure Technologies had 12 more articles in the media than Acme United. MarketBeat recorded 15 mentions for OraSure Technologies and 3 mentions for Acme United. Acme United's average media sentiment score of 0.67 beat OraSure Technologies' score of 0.65 indicating that Acme United is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Acme United	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OraSure Technologies	3 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Acme United has a beta of 0.35, indicating that its share price is 65% less volatile than the broader market. Comparatively, OraSure Technologies has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market.

Acme United presently has a consensus target price of $70.00, suggesting a potential upside of 2.25%. Given Acme United's higher probable upside, research analysts clearly believe Acme United is more favorable than OraSure Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acme United	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

Acme United has higher revenue and earnings than OraSure Technologies. OraSure Technologies is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acme United	$220.55M	1.18	$17.79M	$2.72	25.17
OraSure Technologies	$115.02M	2.17	-$68.73M	-$0.69	N/A

Acme United has a net margin of 10.25% compared to OraSure Technologies' net margin of -41.73%. Acme United's return on equity of 9.70% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Acme United	10.25%	9.70%	6.10%
OraSure Technologies	-41.73%	-19.81%	-16.98%

Summary

Acme United beats OraSure Technologies on 10 of the 16 factors compared between the two stocks.

Get Acme United News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACU vs. The Competition

Export

Metric	Acme United	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$260.83M	$5.96B	$7.84B	$23.48B
Dividend Yield	0.92%	1.68%	2.46%	3.78%
P/E Ratio	14.00	38.39	34.71	27.05
Price / Sales	1.18	5.57	8.66	3.38
Price / Cash	10.02	23.95	21.93	15.51
Price / Book	2.51	4.45	4.35	3.72
Net Income	$17.79M	$143.14M	$3.51B	$1.08B
7 Day Performance	0.12%	-1.25%	-1.49%	0.58%
1 Month Performance	11.53%	-1.30%	-2.55%	1.11%
1 Year Performance	85.68%	1.73%	0.92%	7.21%

Acme United Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACU Acme United	1.9634 of 5 stars	$68.46 -2.5%	$70.00 +2.2%	+84.3%	$260.83M	$220.55M	14.00	649	Insider Trade High Trading Volume
QDEL QuidelOrtho	3.1611 of 5 stars	$14.09 +0.4%	$13.63 -3.3%	-51.6%	$962.11M	$2.73B	10.39	6,500
CERS Cerus	3.0768 of 5 stars	$2.34 -0.8%	$5.25 +124.4%	+24.1%	$475.60M	$206.13M	N/A	345	Gap Down
EMBC Embecta	3.2252 of 5 stars	$6.08 -1.8%	$11.00 +80.9%	-55.2%	$350.72M	$1.08B	3.03	1,850
SMTI Sanara MedTech	0.5468 of 5 stars	$32.17 +0.3%	$35.00 +8.8%	+65.0%	$294.66M	$103.12M	145.77	108	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ACU) was last updated on 11/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Acme United (ACU) Competitors

ACU vs. QDEL, CERS, EMBC, SMTI, and OSUR

How does Acme United compare to QuidelOrtho?

Summary

How does Acme United compare to Cerus?

Summary

How does Acme United compare to Embecta?

Summary

How does Acme United compare to Sanara MedTech?

Summary

How does Acme United compare to OraSure Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACU vs. The Competition

Acme United Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Acme United (ACU) Competitors

ACU vs. QDEL, CERS, EMBC, SMTI, and OSUR

How does Acme United compare to QuidelOrtho?

Do insiders & institutionals have more ownership in ACU or QDEL?

Which has more risk and volatility, ACU or QDEL?

Is ACU or QDEL more profitable?

Which has better valuation and earnings, ACU or QDEL?

Does the media favor ACU or QDEL?

Do analysts prefer ACU or QDEL?

Summary

How does Acme United compare to Cerus?

Which has higher earnings & valuation, ACU or CERS?

Which has more risk and volatility, ACU or CERS?

Do analysts recommend ACU or CERS?

Is ACU or CERS more profitable?

Do institutionals & insiders hold more shares of ACU or CERS?

Does the media favor ACU or CERS?

Summary

How does Acme United compare to Embecta?

Do insiders and institutionals hold more shares of ACU or EMBC?

Which has more risk & volatility, ACU or EMBC?

Which has higher valuation & earnings, ACU or EMBC?

Is ACU or EMBC a better dividend stock?

Do analysts recommend ACU or EMBC?

Is ACU or EMBC more profitable?

Does the media prefer ACU or EMBC?

Summary

How does Acme United compare to Sanara MedTech?

Does the media refer more to SMTI or ACU?

Which has higher valuation and earnings, SMTI or ACU?

Which has more volatility and risk, SMTI or ACU?

Do institutionals & insiders have more ownership in SMTI or ACU?

Is SMTI or ACU more profitable?

Do analysts rate SMTI or ACU?

Summary

How does Acme United compare to OraSure Technologies?

Do insiders & institutionals hold more shares of ACU or OSUR?

Does the media refer more to ACU or OSUR?

Which has more risk and volatility, ACU or OSUR?

Do analysts recommend ACU or OSUR?

Which has better earnings & valuation, ACU or OSUR?

Is ACU or OSUR more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACU vs. The Competition

Acme United Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools